| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 1002 | 2017 |
| Differential Effects of Aripiprazole on D 2 , 5-HT 2 , and 5-HT 1A Receptor Occupancy in Patients With Schizophrenia: A Triple … D Mamo, A Graff, R Mizrahi, CM Shammi, F Romeyer, S Kapur American Journal of Psychiatry 164 (9), 1411-1417, 2007 | 291 | 2007 |
| Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis P León-Ortiz, R Favila, S Stephano, D Mamo, J Ramírez-Bermúdez, ... Neuropsychopharmacology 36 (9), 1781-1791, 2011 | 272 | 2011 |
| Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies S Moriguchi, A Takamiya, Y Noda, N Horita, M Wada, S Tsugawa, ... Molecular psychiatry 24 (7), 952-964, 2019 | 270 | 2019 |
| Cerebral blood flow associated with creative performance: a comparative study RA Chávez-Eakle, A Graff-Guerrero, JC García-Reyna, V Vaugier, ... Neuroimage 38 (3), 519-528, 2007 | 263 | 2007 |
| Kynurenine pathway in depression: A systematic review and meta-analysis K Ogyu, K Kubo, Y Noda, Y Iwata, S Tsugawa, Y Omura, M Wada, ... Neuroscience & Biobehavioral Reviews 90, 16-25, 2018 | 259 | 2018 |
| Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making G Fervaha, A Graff-Guerrero, KK Zakzanis, G Foussias, O Agid, ... Journal of psychiatric research 47 (11), 1590-1596, 2013 | 251 | 2013 |
| Kynurenic acid in schizophrenia: a systematic review and meta-analysis E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ... Schizophrenia bulletin 43 (4), 764-777, 2017 | 225 | 2017 |
| Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation T Suzuki, G Remington, BH Mulsant, H Uchida, TK Rajji, A Graff-Guerrero, ... Psychiatry research 197 (1-2), 1-6, 2012 | 219 | 2012 |
| The potential role of dopamine D3 receptor neurotransmission in cognition S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ... European Neuropsychopharmacology 23 (8), 799-813, 2013 | 214 | 2013 |
| Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ... Frontiers in psychiatry 9, 622, 2018 | 207 | 2018 |
| Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance … C de la Fuente-Sandoval, P León-Ortiz, M Azcárraga, S Stephano, ... JAMA psychiatry 70 (10), 1057-1066, 2013 | 198 | 2013 |
| Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D 2 receptors: a PET study in schizophrenia R Mizrahi, P Rusjan, O Agid, A Graff, DC Mamo, RB Zipursky, S Kapur American Journal of Psychiatry 164 (4), 630-637, 2007 | 191 | 2007 |
| Glutamate-mediated excitotoxicity in schizophrenia: a review E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ... European Neuropsychopharmacology 24 (10), 1591-1605, 2014 | 183 | 2014 |
| Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain A Graff-Guerrero, J González-Olvera, A Fresán, D Gómez-Martín, ... Cognitive Brain Research 25 (1), 153-160, 2005 | 176 | 2005 |
| Individual determinants of COVID-19 vaccine hesitancy P Gerretsen, J Kim, F Caravaggio, L Quilty, M Sanches, S Wells, ... PloS one 16 (11), e0258462, 2021 | 165 | 2021 |
| Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis H Uchida, H Takeuchi, A Graff-Guerrero, T Suzuki, K Watanabe, ... Journal of clinical psychopharmacology 31 (4), 497-502, 2011 | 165 | 2011 |
| Motivational deficits and cognitive test performance in schizophrenia G Fervaha, KK Zakzanis, G Foussias, A Graff-Guerrero, O Agid, ... JAMA psychiatry 71 (9), 1058-1065, 2014 | 162 | 2014 |
| Theta-gamma coupling and working memory in Alzheimer’s dementia and mild cognitive impairment MS Goodman, S Kumar, R Zomorrodi, Z Ghazala, ASM Cheam, MS Barr, ... Frontiers in aging neuroscience 10, 101, 2018 | 161 | 2018 |
| Treatment resistant schizophrenia and response to antipsychotics: a review T Suzuki, G Remington, BH Mulsant, TK Rajji, H Uchida, A Graff-Guerrero, ... Schizophrenia research 133 (1-3), 54-62, 2011 | 155 | 2011 |
